Latest SNIPR Biome News & Updates

See the latest news and media coverage for SNIPR. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
SNIPR Biome (SNIPR)

Biotechnology company developing CRISPR-based medicines for bacterial infections

sniprbiome.com
Headquarters
Copenhagen, Denmark
Company type
Private company
Number of employees
50–52

Last updated

Latest news about SNIPR Biome (SNIPR)

In short: SNIPR enrolled the first patient in its Phase 2 SNIPR001 trial.

Company announcements

SNIPR

SNIPR receives up to EUR 20 million from the European Investment Bank

The financing, backed under HERA Invest as part of the European Commission's InvestEU initiative, funds medicines for infections where antibiotics fail.

Unlock all announcements with a

Media coverage

StreetInsider

SNIPR BIOME Announces FDA Clearance of Investigational New Drug (IND) Application for SNIPR001, a Novel CRISPR Therapy Targeting Life-Threatening E. coli Infections

COPENHAGEN, Denmark, Jan. 11, 2022 /PRNewswire/ -- SNIPR BIOME ApS, a leading CRISPR and microbiome biotechnology company, is pleased to announce that the US Food...

Unlock all articles with a

Never miss news about SNIPR

Track SNIPR and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.